Prot #R668-EE-1324: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis

Project: Research project

Project Details

StatusFinished
Effective start/end date6/25/15 → 6/25/18

Funding

  • Regeneron Pharmaceuticals, Inc. (Prot #R668-EE-1324)